New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
Oncology February 18,2024
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
Oncology February 18,2024
Research identifies new target that may prevent blood cancer

Research identifies new target that may prevent blood cancer

by Bill Snyder,Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainAn international coalition of biomedical researchers co-led by Alexander Bick, MD, Ph.D., at Vanderbilt Unive
Oncology February 18,2024
Research identifies new target that may prevent blood cancer

Research identifies new target that may prevent blood cancer

by Bill Snyder,Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainAn international coalition of biomedical researchers co-led by Alexander Bick, MD, Ph.D., at Vanderbilt Unive
Oncology February 18,2024
A CAR T cell therapy for advanced ovarian cancer developed

A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o
Oncology February 18,2024
A CAR T cell therapy for advanced ovarian cancer developed

A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o
Oncology February 18,2024
'Collateral damage' from normal cell function may cause mutations that play a role in cancer

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S
Oncology February 18,2024
'Collateral damage' from normal cell function may cause mutations that play a role in cancer

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S
Oncology February 18,2024
Genetics may identify breast cancer patients who can safely omit radiation therapy after breast-conserving surgery

Genetics may identify breast cancer patients who can safely omit radiation therapy after breast-conserving surgery

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with invasive breast cancer who had low scores on an investigational gene molecular signature had similar rat
Genesiology February 18,2024
Genetics may identify breast cancer patients who can safely omit radiation therapy after breast-conserving surgery

Genetics may identify breast cancer patients who can safely omit radiation therapy after breast-conserving surgery

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with invasive breast cancer who had low scores on an investigational gene molecular signature had similar rat
Genesiology February 18,2024
Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

by Edith Cowan UniversityA single bout of exercise has been found to produce anti-cancer proteins called myokines which can significantly inhibit tumour growth even in advanced stages of the dise
Immunology & Rheumatology February 18,2024
Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

by Edith Cowan UniversityA single bout of exercise has been found to produce anti-cancer proteins called myokines which can significantly inhibit tumour growth even in advanced stages of the dise
Immunology & Rheumatology February 18,2024
Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm
Oncology February 18,2024
Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm
Oncology February 18,2024
Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

by Barcelona Institute for Global HealthCredit: Pixabay/CC0 Public DomainThe nitrate ingested over the course of a person's adult lifetime through the consumption of tap water and bottled wat
Oncology February 18,2024
Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

by Barcelona Institute for Global HealthCredit: Pixabay/CC0 Public DomainThe nitrate ingested over the course of a person's adult lifetime through the consumption of tap water and bottled wat
Oncology February 18,2024
Researchers develop new marker for cancer cell motility

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more
Oncology February 18,2024
Researchers develop new marker for cancer cell motility

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more
Oncology February 18,2024
New immunotherapy targeting tumor macrophages to tackle lung cancer

New immunotherapy targeting tumor macrophages to tackle lung cancer

by Germans Trias i Pujol Research InstituteRImAb modifies the intratumoral myeloid cell compartment in a mouse model of LLC. a) Myeloid cell gating classification using the expression of surface marke
Oncology February 18,2024
New immunotherapy targeting tumor macrophages to tackle lung cancer

New immunotherapy targeting tumor macrophages to tackle lung cancer

by Germans Trias i Pujol Research InstituteRImAb modifies the intratumoral myeloid cell compartment in a mouse model of LLC. a) Myeloid cell gating classification using the expression of surface marke
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com